Using the L1CAM immunocapture approach in plasma, Goeztl et al. also reported a reduction in the abundance of synaptic proteins synaptotagmin and synaptopodin in FTD (which was also seen in AD participants), although this study did not distinguish between TDP-43 and tau-related disease [198]. This evidence concerns the gene MAPT and Alzheimer disease.